AI Science Tracker
EN

Department of Media, Soongsil University, Seoul, Korea.

1 discovery from 2023

Discoveries

Artificial Intelligence-Based Patient Monitoring System for Medical Support.

Source check: Source checked. Not independent scientific confirmation.

Finding: Patient monitoring model predicts neurogenic risk with reported measured accuracy. The publisher Methods and Results were checked; this conclusion is limited to the study cohort, reference standard and validation described there. AI role: Recurrent neural network for activity recognition and CNN for risk prediction. The article appeared in International Neurourology Journal.

Technology: Recurrent neural network for activity recognition and CNN for risk prediction

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Recurrent neural network for activity recognition and CNN for risk prediction
Test and result
Patient monitoring model predicts neurogenic risk with reported measured accuracy. The publisher Methods and Results were checked; this conclusion is limited to the study cohort, reference standard and validation described there.
Limitation / still unknown
The result is limited to the described dataset, cohort, experimental system, or validation design; generalization beyond that scope and downstream real-world benefit are not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10762372/ · https://pubmed.ncbi.nlm.nih.gov/38171328/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.